Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Enzo Life Sciences GW9508 (50mg). CAS: 885101-89-3
SDP

Supplier:  Enzo Life Sciences BMLGP1020050

Encompass_Preferred

First high potency synthetic agonist at GPR40. GPR40 was formerly an orphan GPCR whose endogenous ligands have been shown to be free fatty acids and has therefore been designated the free fatty acid receptor 1 (FFAR1). It is abundantly expressed on insulin-expressing beta cells and has been shown to mediate the majority of the effects of free fatty acids on insulin secretion. GW9508 enhanced insulin secretion in INS-1E cells and activates ATP-sensitive potassium channels in rat pancreatic beta cells (40μM). It is a useful tool for exploring the biology of GPR40 mediated signaling and physiology. Alternative name: 4-[[(3-Phenoxyphenyl)methyl]amino]benzene propanoic acid. Purity: ≥98% (TLC). Solubility: Soluble in DMSO (15mg/ml). Long Term Storage: Ambient.

Catalog No. 50-201-0904


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.